Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Crispr Therapeutics Ag (CRSP)  
$51.17 2.38 (4.44%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 70,650,000
Market Cap: 3.62(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $38.62 - $89.12
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CRISPR Therapeutics is a gene editing company focused on the development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) based therapeutics. CRISPR/Cas9 is a technology for gene editing, the process of altering specific sequences of genomic DNA. Co. is developing several gene-edited allogeneic cell therapy programs. Co.'s main product candidate, CTX001, is an investigational ex vivo CRISPR gene-edited therapy that is being evaluated for patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce fetal hemoglobin in red blood cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 89,721 159,721 184,721 409,721
Total Sell Value $6,558,882 $10,834,513 $12,456,407 $25,314,056
Total People Sold 3 3 3 3
Total Sell Transactions 10 12 13 22
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 483
  Page 8 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bolzon Bradley J Phd Director   –       •      –    2020-09-09 4 A $0.00 $0 I/I 42,272 42,272     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2020-09-02 4 D $94.15 $73,343 D/D (779) 169,968     -
   Tomsicek Michael John Chief Financial Officer   •       –      –    2020-09-01 4 AS $91.39 $1,107,068 D/D (12,000) 410 107%     
   Tomsicek Michael John Chief Financial Officer   •       –      –    2020-09-01 4 OE $17.75 $213,000 D/D 12,000 12,410     -
   Novak Rodger President   •       •      –    2020-09-01 4 AS $91.54 $2,315,578 D/D (25,000) 648,007 107%     
   Novak Rodger President   •       •      –    2020-09-01 4 OE $14.00 $359,059 D/D 25,000 673,007     -
   Bolzon Bradley J Phd Director   –       •      –    2020-09-01 4 S $91.27 $5,550,644 I/I (60,000) 0 -107%     
   Bolzon Bradley J Phd Director   –       •      –    2020-09-01 4 OE $13.62 $1,513,950 I/I 60,000 60,000     -
   Novak Rodger President   •       •      –    2020-08-19 4 AS $100.00 $2,500,000 D/D (25,000) 648,007 52%     
   Novak Rodger President   •       •      –    2020-08-19 4 OE $14.00 $350,000 D/D 25,000 673,007     -
   Behbahani Ali Director   –       •      –    2020-08-13 4 A $0.00 $0 I/I 14 14     -
   Behbahani Ali Director   –       •      –    2020-08-13 4 A $0.00 $0 D/D 57 256     -
   Tomsicek Michael John Chief Financial Officer   •       –      –    2020-08-03 4 AS $86.25 $1,040,919 D/D (12,000) 410 62%     
   Tomsicek Michael John Chief Financial Officer   •       –      –    2020-08-03 4 OE $17.75 $213,000 D/D 12,000 12,410     -
   Novak Rodger President   •       •      –    2020-07-07 4 AS $90.00 $2,250,000 D/D (25,000) 648,007 17%     
   Novak Rodger President   •       •      –    2020-07-07 4 OE $1.81 $281,907 D/D 25,000 673,007     -
   Bolzon Bradley J Phd Director   –       •      –    2020-07-06 4 AS $82.16 $1,647,730 I/I (20,000) 554,190 24%     
   Novak Rodger President   •       •      –    2020-07-01 4 AS $80.00 $4,000,000 D/D (50,000) 648,007 28%     
   Klein Lawrence Otto CBO & COO   •       –      –    2020-06-25 4 AS $75.18 $369,272 D/D (4,912) 20,000 36%     
   Klein Lawrence Otto CBO & COO   •       –      –    2020-06-25 4 OE $12.57 $61,744 D/D 4,912 24,912     -
   Klein Lawrence Otto CBO & COO   •       –      –    2020-06-24 4 AS $74.90 $4,942,292 D/D (65,088) 20,000 31%     
   Klein Lawrence Otto CBO & COO   •       –      –    2020-06-24 4 OE $5.86 $558,707 D/D 65,088 46,422     -
   Novak Rodger President   •       •      –    2020-06-23 4 AS $75.00 $3,750,000 D/D (50,000) 698,007 15%     
   Bolzon Bradley J Phd Director   –       •      –    2020-06-23 4 AS $75.35 $753,453 I/I (10,000) 574,190 15%     
   Ho Tony W Executive VP, Head of R&D   •       –      –    2020-06-23 4 AS $75.20 $521,061 D/D (6,929) 33,747 15%     
  483 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us